Tennessee to Share in Diabetes Company's Settlement

Diabetic supply firm AmMed Direct will pay an $18 million penalty to settle government claims that it wrongly billed Medicare for diabetes testing supplies and other products in a bait-and-switch scheme. The penalties, which also include a $2.8 million payment to a whistleblower in the long-running dispute, were revealed Friday by the U.S. Attorney’s Office. Most of the money -- $17.6 million -- will go to the U.S. government with the state of Tennessee getting $439,003 as part of the civil settlement. The Tennessean has the details